기업 정보 불러오는 중
Keep exploring
The themes Johnson & Johnson is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The themes it is part of
- 큐레이션
Medical devices
InspectStocks 제공 · 20 companies
Surgical robots, implants, heart devices, glucose monitors and other medical equipment.
- 주가, 1년
- +6.2%
- 매출, 1년
- +7.2%
+14A 8B 7C 3D 2
- 큐레이션
Big pharma
InspectStocks 제공 · 13 companies
The largest drugmakers, selling prescription medicines worldwide.
- 주가, 1년
- +41.6%
- 매출, 1년
- +10.8%
+7A 7B 3C 3
Highest-graded in Drug Manufacturers General
Graded A or B and worth $2B or more: A first, then the largest.
- LLYELI Lilly And CompanyUS$1.36TA+
- MRKMerck & Co., Inc.US$364.3BA
- NVSNovartis AGUS$306.3BA
AMGNAmgen Inc.US$251.9BA+
GILDGilead Sciences, Inc.US$208.4BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026년 10월 21일CBGraded C, now B
MCKMckesson Corporation2026년 11월 4일BAGraded B, now A
CVSCVS Health Corp2026년 11월 4일BAGraded B, now A
EWEdwards Lifesciences Corporation2026년 11월 4일BAGraded B, now A
GEHCGE Healthcare Technologies Inc.2026년 10월 28일CAGraded C, now A
어떻게 돈을 버는가
- Innovative Medicine64%
- MedTech36%
매출 비중은 six months ended June 28, 2026, high confidence 기준 추정치이며, 제출된 보고서의 수치가 아닙니다.
경쟁 상대
무엇을 파는가6
DARZALEX
A medicine used to treat multiple myeloma, a cancer of plasma cells.
TREMFYA
A medicine for conditions including plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
CARVYKTI
A treatment made from a patient’s modified immune cells for multiple myeloma that has returned or has not responded to earlier treatment.
3개 더 보기
VARIPULSE
A system that uses pulsed electrical energy to treat atrial fibrillation, a disorder that causes an irregular heartbeat.
Impella
A heart pump used to support blood circulation in certain patients with heart failure or during high-risk heart procedures.
ACUVUE
A brand of contact lenses sold for vision correction.
누가 사는가4
- Wholesalers, distributors and retailers that buy medicines and medical products for resale.
- Hospitals and clinics that buy medicines and devices for patient care and procedures.
- Physicians and other healthcare professionals who prescribe medicines or use medical devices in treatment.
- Eye-care professionals and retailers that supply contact lenses and other vision products.
무엇에 기대고 있고, 무엇이 무너뜨릴 수 있는가
사업이 기대고 있는 것
- 1Some medicines rely on licenses or partnerships with other companies. For example, a subsidiary licenses patent families related to DARZALEX from Genmab, and IMBRUVICA is co-commercialized in the United States with Pharmacyclics, an AbbVie company.
- 2The company depends on government approvals and ongoing oversight for its medicines and medical devices, including rules on safety, manufacturing, labeling and sales.
- 3Sales depend partly on health insurers and government programs deciding whether to cover products and how much they will reimburse; U.S. and other governments can also change medicine-pricing rules.
- 4The company uses third parties to make or supply some products and relies on complex international manufacturing and distribution chains.
잘못될 수 있는 일
- 1Generic and biosimilar competition can reduce sales of medicines when alternatives enter the market. The latest quarterly report describes continuing sales declines for STELARA and says biosimilar competition is also affecting other medicines.
- 2Government pricing rules, coverage decisions and reimbursement changes can affect what the company receives for medicines and medical devices. The company identifies U.S. drug-pricing measures and tighter regulation across markets as concerns.
- 3Lawsuits and product-safety claims can lead to substantial costs and affect sales or reputation. The latest quarterly report recorded charges related to talc litigation.
Johnson & Johnson 소개
Johnson & Johnson develops, makes and sells prescription medicines and medical devices around the world. Its two businesses are Innovative Medicine, which sells medicines for conditions including cancer and immune disorders, and MedTech, which sells products used in heart procedures, surgery, orthopaedics and vision care.
- 본사
- New Brunswick, New Jersey
- 설립
- 1887 (founding year, high confidence)
- 임직원 수
- 140,800 (December 28, 2025, high confidence)
- 상장 시장
- New York Stock Exchange
- 회계연도 종료
- Last Sunday in December
Johnson & Johnson이(가) 미국 증권거래위원회(SEC)에 직접 제출한 공시로 만들었습니다. 수치는 보고된 그대로이며, 주당 이력은 오늘의 주식 수 기준으로 재계산했습니다. 이것은 사업을 설명하는 자료입니다. 투자 자문이 아니며 어떤 매수나 매도도 권유하지 않습니다.